Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?
{{output}}
Background: Cancer is first and foremost a disease of the genome. Specific genetic signatures within a tumour are prognostic of disease outcome, reflect subclonal architecture and intratumour heterogeneity, inform treatment choic... ...
